B-细胞激活因子(BAFF)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for B-Cell Activating Factor (BAFF)
CD257; TNFSF13B; BLYS; TALL1; THANK; TNFSF20; ZTNF4; B lymphocyte stimulator; Tumor Necrosis Factor Ligand Superfamily Member 13B; Dendritic cell-derived TNF-like
- 编号SEB686Mu
- 物种Mus musculus (Mouse,小鼠) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3h
- 检测范围12.5-800pg/mL
- 灵敏度最小可检测剂量小于等于5.1pg/mL.
- 样本类型serum, plasma, tissue homogenates and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 48T96T 96T*5 96T*10 96T*100
- 价格 ¥ 2873 ¥ 4104 ¥ 18468 ¥ 34884 ¥ 287280
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测B-细胞激活因子(BAFF),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的B-细胞激活因子(BAFF)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 79-102 | 97 |
EDTA plasma(n=5) | 97-104 | 101 |
heparin plasma(n=5) | 98-105 | 102 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的B-细胞激活因子(BAFF),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中B-细胞激活因子(BAFF)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 81-89% | 82-91% | 86-105% | 91-99% |
EDTA plasma(n=5) | 80-102% | 91-98% | 80-103% | 94-101% |
heparin plasma(n=5) | 78-97% | 92-99% | 87-96% | 96-105% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。
实验原理
将B-细胞激活因子(BAFF)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的B-细胞激活因子(BAFF)与连接于固相载体上的抗体结合,然后加入生物素化的B-细胞激活因子(BAFF)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的B-细胞激活因子(BAFF)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
编号 | 适用物种:Mus musculus (Mouse,小鼠) | 应用(仅供研究使用,不用于临床诊断!) |
RPB686Mu02 | B-细胞激活因子(BAFF)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB686Mu01 | B-细胞激活因子(BAFF)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB686Mu02 | B-细胞激活因子(BAFF)多克隆抗体 | WB; IHC; ICC; IP. |
PAB686Mu01 | B-细胞激活因子(BAFF)多克隆抗体 | WB; IHC; ICC; IP. |
LAB686Mu71 | B-细胞激活因子(BAFF)多克隆抗体(生物素标记) | WB; IHC; ICC. |
SEB686Mu | B-细胞激活因子(BAFF)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB686Mu | B-细胞激活因子(BAFF)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
International Immunopharmacology | Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis [Pubmed:25598291] |
Int Immunopharmacol | BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats [PubMed: 26688104] |
Clinical Rheumatology | Metabolic syndrome in Sj [PubMed: 26370103] |
Transplantation | Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model. [PubMed: 25919767] |
Rheumatology | Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary … [rheumatology.kew332.abstract] |
Clinical Immunology | Toll-like receptor 9 ligands increase type I interferon induced B-cell activating factor expression in chronic rhinosinusitis with nasal polyposis [Pubmed:30056130] |
Gene | A Significant Decrease of BAFF, APRIL, and BAFF Receptors Following Mesenchymal Stem Cell Transplantation in Patients with Refractory Rheumatoid Arthritis [Pubmed: 31935514] |
american journal of physiology-renal physiology | The expression of XBP1s in B lymphocytes is critical for pristane-induced lupusnephritis in mice [Pubmed: 32249615] |
diagnostics | Interstitial Score and Concentrations of IL-4R¦Á, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial?¡ [33924683] |